Painful peripheral neuropathy and sodium channel mutations

Neuroscience Letters

Volumn 596, Issue , 2015, Pages 51-59

  Hoeijmakers, Janneke G J ^a   Faber, Catharina G ^a   Merkies, Ingemar S J ^a,b   Waxman, Stephen G ^c,d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Painful peripheral neuropathy; Small fiber neuropathy; Voltage gated sodium channels

Indexed keywords

VOLTAGE GATED SODIUM CHANNEL;

GENETICS; HUMAN; METABOLISM; MUTATION; NERVE CELL; NERVE FIBER; NEURALGIA; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; SPINAL GANGLION;

AXONS; GANGLIA, SPINAL; HUMANS; MUTATION; NEURALGIA; NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84939967760     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.12.056     Document Type: Review

References (59)

1. England J.D., Gronseth G.S., Franklin G., Miller R.G., Asbury A.K., Carter G.T., Cohen J.A., Fisher M.A., Howard J.F., Kinsella L.J., Latov N., Lewis R.A., Low P.A., Sumner A.J. N. American Academy of, N. American Association of Electrodiagnostic, M. American Academy of Physical, Rehabilitation, Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005, 64:199-207.
2. England J.D., Asbury A.K. Peripheral neuropathy. Lancet 2004, 363:2151-2161.
3. Hoeijmakers J.G., Faber C.G., Lauria G., Merkies I.S., Waxman S.G. Small-fibre neuropathies - advances in diagnosis, pathophysiology and management. Nat. Rev. Neurol. 2012, 8:369-379.
4. Dubin A.E., Patapoutian A. Nociceptors: the sensors of the pain pathway. J. Clin. Invest. 2010, 120:3760-3772.
5. Lauria G., Merkies I.S.J., Waxman S.G., Faber C.G. Epidermal Nerve Fibers 2014, vol. 2. Academic Press, Oxford.
6. Woolf C.J., Ma Q. Nociceptors - noxious stimulus detectors. Neuron 2007, 55:353-364.
7. Holzer P., Maggi C.A. Dissociation of dorsal root ganglion neurons into afferent and efferent-like neurons. Neuroscience 1998, 86:389-398.
8. Baron R. Peripheral neuropathic pain: from mechanisms to symptoms. Clin. J. Pain 2000, 16:S12-20.
9. Lee Y., Lee C.H., Oh U. Painful channels in sensory neurons. Mol. Cells 2005, 20:315-324.
10. Aurilio C., Pota V., Pace M.C., Passavanti M.B., Barbarisi M. Ionic channels and neuropathic pain: physiopathology and applications. J. Cell Physiol. 2008, 215:8-14.
11. Waxman S.G., Zamponi G.W. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat. Neurosci. 2014, 17:153-163.
12. Cox J.J., Reimann F., Nicholas A.K., Thornton G., Roberts E., Springell K., Karbani G., Jafri H., Mannan J., Raashid Y., Al-Gazali L., Hamamy H., Valente E.M., Gorman S., Williams R., McHale D.P., Wood J.N., Gribble F.M., Woods C.G. An SCN9A channelopathy causes congenital inability to experience pain. Nature 2006, 444:894-898.
13. Yang Y., Wang Y., Li S., Xu Z., Li H., Ma L., Fan J., Bu D., Liu B., Fan Z., Wu G., Jin J., Ding B., Zhu X., Shen Y. Mutations in SCN9A encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 2004, 41:171-174.
14. Fertleman C.R., Baker M.D., Parker K.A., Moffatt S., Elmslie F.V., Abrahamsen B., Ostman J., Klugbauer N., Wood J.N., Gardiner R.M., Rees M. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 2006, 52:767-774.
15. Leipold E., Liebmann L., Korenke G.C., Heinrich T., Giesselmann S., Baets J., Ebbinghaus M., Goral R.O., Stodberg T., Hennings J.C., Bergmann M., Altmuller J., Thiele H., Wetzel A., Nurnberg P., Timmerman V., De Jonghe P., Blum R., Schaible H.G., Weis J., Heinemann S.H., Hubner C.A., Kurth I. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat. Genet. 2013, 45:1399-1404.
16. Zhang X.Y., Wen J., Yang W., Wang C., Gao L., Zheng L.H., Wang T., Ran K., Li Y., Li X., Xu M., Luo J., Feng S., Ma X., Ma H., Chai Z., Zhou Z., Yao J., Zhang X., Liu J.Y. Gain-of-function mutations in SCN11A cause familial episodic pain. Am. J. Hum. Genet. 2013, 93:957-966.
17. 2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
18. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 2003, 33:192-196.
19. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371-377.
20. V1.7 mutations in idiopathic small fiber neuropathy. Ann. Neurol. 2012, 71:26-39.
21. V1.8 mutations in painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:19444-19449.
22. V1.9 in painful neuropathy. Brain 2014, 137:1627-1642.
23. Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 1952, 117:500-544.
24. Catterall W.A., Goldin A.L., Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57:397-409.
25. Goldin A.L. Diversity of mammalian voltage-gated sodium channels. Ann. N.Y. Acad. Sci. 1999, 868:38-50.
26. Catterall W.A. Ion channel voltage sensors: structure, function, and pathophysiology. Neuron 2010, 67:915-928.
27. Payandeh J., Scheuer T., Zheng N., Catterall W.A. The crystal structure of a voltage-gated sodium channel. Nature 2011, 475:353-358.
28. 2+ in the voltage-gated sodium channel. Biophys. J. 1996, 71:3110-3125.
29. Stuhmer W., Conti F., Suzuki H., Wang X.D., Noda M., Yahagi N., Kubo H., Numa S. Structural parts involved in activation and inactivation of the sodium channel. Nature 1989, 339:597-603.
30. Vassilev P.M., Scheuer T., Catterall W.A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science 1988, 241:1658-1661.
31. Goldin A.L. Mechanisms of sodium channel inactivation. Curr. Opin. Neurobiol. 2003, 13:284-290.
32. Mitrovic N., George A.L., Horn R. Role of domain 4 in sodium channel slow inactivation. J. Gen. Physiol. 2000, 115:707-718.
33. Dib-Hajj S.D., Binshtok A.M., Cummins T.R., Jarvis M.F., Samad T., Zimmermann K. Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment. Brain Res. Rev. 2009, 60:65-83.
34. Dib-Hajj S.D., Cummins T.R., Black J.A., Waxman S.G. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 2010, 33:325-347.
35. V1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5616-5620.
36. V1.6 sodium channels to axon initial segments and nodes of Ranvier. J. Neurosci. 2012, 32:7232-7243.
37. V1.6 is expressed along nonmyelinated axons and it contributes to conduction. Brain Res. Mol. Brain Res. 2002, 105:19-28.
38. Waxman S.G., Kocsis J.D., Black J.A. Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J. Neurophysiol. 1994, 72:466-470.
39. V1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain. Mol. Ther. 2013, 21:49-56.
40. V1.7 sodium channel: from molecule to man. Nat. Rev. Neurosci. 2013, 14:49-62.
41. V1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J. Neurosci. 2006, 26:12566-12575.
42. Waxman S.G., Merkies I.S., Gerrits M.M., Dib-Hajj S., Lauria G., Cox J.J., Wood J.N., Woods C.G., Drenth J.P., Faber C.G. Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use. Lancet Neurol. 2014, 13:1152-1160.
43. Wallis T., Payne S., McAnulty C., Bodmer D., Sistermans E., Robertson K., Moore D., Abbs S., Deans Z., Devereau A. Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics 2013, Association for Clinical Genetic Science (ACGS), Birmingham.
44. V1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability. Neurology 2012, 78:1635-1643.
45. V1.7. Mol. Pain 2011, 7:92.
46. Han C., Hoeijmakers J.G., Liu S., Gerrits M.M., te Morsche R.H., Lauria G., Dib-Hajj S.D., Drenth J.P., Faber C.G., Merkies I.S., Waxman S.G. Functional profiles of SCN9A variants in dorsal root ganglion neurons and superior cervical ganglion neurons correlate with autonomic symptoms in small fibre neuropathy. Brain 2012, 135:2613-2628.
47. V1.7 sodium channels on resting potential and interspike membrane potential of dorsal root ganglion neurons. Brain Res. 2013, 1529:165-177.
48. Hoeijmakers J.G., Faber C.G., Merkies I.S., Waxman S.G. Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?. Trends Mol. Med. 2014, 20:544-550.
49. V1.7 mutation. Pain 2014, 155:1702-1707.
50. V1.7 mutation. Brain 2012, 135:345-358.
51. V1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons. J. Neurosci. 2013, 33:14087-14097.
52. V1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability. J. Neurol. Neurosurg. Psychiatry 2014, 85:499-505.
53. Persson A.K., Black J.A., Gasser A., Cheng X., Fischer T.Z., Waxman S.G. Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals. Mol. Pain 2010, 6:84.
54. 2+ influx during anoxia in mammalian central nervous system white matter. Ann. Neurol. 1991, 30:375-380.
55. Garthwaite G., Goodwin D.A., Batchelor A.M., Leeming K., Garthwaite J. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002, 109:145-155.
56. V1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons. Ann. Neurol. 2013, 73:140-145.
57. Dib-Hajj S.D., Waxman S.G. Translational pain research: lessons from genetics and genomics. Sci. Trans. Med. 2014, 6:249sr244.
58. Bakkers M., Faber C.G., Hoeijmakers J.G., Lauria G., Merkies I.S. Small fibers, large impact: quality of life in small-fiber neuropathy. Muscle Nerve 2014, 49:329-336.
59. Attal N., Cruccu G., Baron R., Haanpaa M., Hansson P., Jensen T.S., Nurmikko T. S. European Federation of Neurological, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 2010, 17:1113-e1188.